(Q73371204)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738056%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

MDMA

0 references

title

Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738056%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1 reference

Johnalyn Lyles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738056%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Jean Lud Cadet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738056%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12738056

31 December 2023

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738056%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://api.elsevier.com/content/article/PII:S0165017303001735?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

https://api.elsevier.com/content/article/PII:S0165017303001735?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

Brain research. Brain research reviews

31 December 2023

published in

42

2

155–68

May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12738056

31 December 2023

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738056%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738056%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

155-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738056%20AND%20SRC:MED&resulttype=core&format=json

Developmental pattern of reactive oxygen species generation and antioxidative defense machinery in rat cerebral microvessels.

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Glutamate neurotoxicity, oxidative stress and mitochondria.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Memory impairment in abstinent MDMA ("Ecstasy") users.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effects of designer drugs on the chicken embryo and 1-day-old chicken.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy")

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Subjective reports on the effects of the MDMA ('ecstasy') experience in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Expression of copper/zinc superoxide dismutase and glutathione peroxidase in organs of developing mouse embryos, fetuses, and neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Pharmacology of MDMA in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The psychological and physiological effects of MDMA on normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Acute renal failure after ecstasy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Orally administered MDMA causes a long-term depletion of serotonin in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Twenty-four hour rhythms of selected ambient temperature in rat and hamster

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Subjective reports of the effects of MDMA in a clinical setting.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Serotonin transporters in ecstasy users.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

[3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Toxic effect of MDMA on brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

MDMA induced dopamine release in vivo: role of endogenous serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

3,4-Methylenedioxymethamphetamine ('Ecstasy') promotes the translocation of protein kinase C (PKC): requirement of viable serotonin nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The neuropsychopharmacology of criminality and aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

MDMA and memory: the acute and chronic effects of MDMA in pigeons performing under a delayed-matching-to-sample procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Gender differences in the subjective effects of MDMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Acute Toxicity of 3,4-Methylenedioxymethamphetamine (MDMA) in Sprague–Dawley and Dark Agouti Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy')

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Congenital anomalies after prenatal ecstasy exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Neurotoxicity of MDMA and related compounds: anatomic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Ecstasy use and neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Memory deficits associated with recreational use of "ecstasy" (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effect of 3,4-Methylenedioxymethamphetamine on 3,4-Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin synthesis in the dog studied by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Methylenedioxymethamphetamine-induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Assessing long-term effects of MDMA (Ecstasy).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

A new pharmophoric model for 5-HT reuptake-inhibitors: differentiation of amphetamine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Age dependence of the level of the enzymes involved in the protection against active oxygen species in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Neurotoxicity of MDMA: neurochemical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

CSF studies in violent offenders. I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Nitric oxide-dependent damage to neuronal mitochondria involves the NMDA receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Cognitive performance and serotonergic function in users of ecstasy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Working memory deficits in current and previous users of MDMA ('ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Adverse effects of stimulant drugs in a community sample of drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Fetal exposure to (+/-)-methylenedioxymethamphetamine in utero enhances the development and metabolism of serotonergic neurons in three-dimensional reaggregate tissue culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2803%2900173-5

7 January 2021

Rat lung antioxidant enzymes: differences in perinatal gene expression and regulation

27

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat

31 December 2023

90

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors

31 December 2023

113

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine

31 December 2023

115

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA

31 December 2023

130

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans

31 December 2023

135

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa

31 December 2023

157

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction

31 December 2023

161

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine

31 December 2023

171

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine

31 December 2023

179

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine

31 December 2023

182

1 reference

https://api.crossref.org/works/10.1016/S0165-0173(03)00173-5

31 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12738056%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference